Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cellular DNA content and survival in advanced ovarian carcinoma.
Pfisterer J, Kommoss F, Sauerbrei W, Renz H, du Bois A, Kiechle-Schwarz M, Pfleiderer A. Pfisterer J, et al. Among authors: du bois a. Cancer. 1994 Nov 1;74(9):2509-15. doi: 10.1002/1097-0142(19941101)74:9<2509::aid-cncr2820740919>3.0.co;2-f. Cancer. 1994. PMID: 7923008
[Value of high resolution sonography in breast cancer screening].
Madjar H, Makowiec U, Mundinger A, Du Bois A, Kommoss F, Schillinger H. Madjar H, et al. Among authors: du bois a. Ultraschall Med. 1994 Feb;15(1):20-3. doi: 10.1055/s-2007-1003999. Ultraschall Med. 1994. PMID: 8165458 German.
Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel.
Kommoss F, Kommoss S, Schmidt D, Trunk MJ, Pfisterer J, du Bois A; Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom. Kommoss F, et al. Among authors: du bois a. Gynecol Oncol. 2005 Apr;97(1):195-9. doi: 10.1016/j.ygyno.2004.12.047. Gynecol Oncol. 2005. PMID: 15790458 Clinical Trial.
Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Kommoss S, du Bois A, Ridder R, Trunk MJ, Schmidt D, Pfisterer J, Kommoss F; AGO-OVAR. Kommoss S, et al. Among authors: du bois a. Br J Cancer. 2007 Jan 29;96(2):306-13. doi: 10.1038/sj.bjc.6603531. Br J Cancer. 2007. PMID: 17242700 Free PMC article. Clinical Trial.
NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
Engels K, Knauer SK, Loibl S, Fetz V, Harter P, Schweitzer A, Fisseler-Eckhoff A, Kommoss F, Hanker L, Nekljudova V, Hermanns I, Kleinert H, Mann W, du Bois A, Stauber RH. Engels K, et al. Among authors: du bois a. Cancer Res. 2008 Jul 1;68(13):5159-66. doi: 10.1158/0008-5472.CAN-08-0406. Cancer Res. 2008. PMID: 18593915
568 results